Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

James C. Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1875-3962; OpenAlex author ID A5043534982. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2007: 1 trial · 2008: none · 2009: none · 2010: 1 trial · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. PPARδ: An underappreciated tumor accelerator in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218385↗
  2. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/oncolo/oyae182↗
  3. Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice Co-author DOI 10.1101/2020.12.04.412320↗

Trials 2

  1. Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Principal investigator NCT01204476↗
  2. Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Principal investigator NCT00454363↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daoyan Wei · 2 shared papers, 2020–2026 · strength 0.45
  2. Yi Liu · 2 shared papers, 2020–2026 · strength 0.45
  3. Xiangsheng Zuo · 2 shared papers, 2020–2026 · strength 0.45
  4. Imad Shureiqi · 2 shared papers, 2020–2026 · strength 0.45
  5. Danping Niu · 1 shared paper, 2026 · strength 0.36
  6. Huamin Wang · 2 shared papers, 2020–2025 · strength 0.29
  7. Michael James Overman · 1 shared paper, 2025 · strength 0.19
  8. Matthew H. G. Katz · 1 shared paper, 2025 · strength 0.19
  9. Dan Zhao · 1 shared paper, 2025 · strength 0.19
  10. Abdelrahman M.G. Yousef · 1 shared paper, 2025 · strength 0.19
  11. Robert A. Wolff · 1 shared paper, 2025 · strength 0.19
  12. Mahmoud Yousef · 1 shared paper, 2025 · strength 0.19
  13. Rebecca Anne Snyder · 1 shared paper, 2025 · strength 0.19
  14. Ethan Bernard Ludmir · 1 shared paper, 2025 · strength 0.19
  15. Anirban Maitra · 1 shared paper, 2025 · strength 0.19
  16. Eugene Jon Koay · 1 shared paper, 2025 · strength 0.19
  17. Brandon George Smaglo · 1 shared paper, 2025 · strength 0.19
  18. Shubham Pant · 1 shared paper, 2025 · strength 0.19
  19. Ching-Wei David Tzeng · 1 shared paper, 2025 · strength 0.19
  20. Xiaofeng Zheng · 1 shared paper, 2020 · strength 0.09
  21. Baoan Ji · 1 shared paper, 2020 · strength 0.09
  22. Donghui Li · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.